Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma

Serum carbohydrate antigen 19-9 (CA19-9) is widely used to predict the prognosis for pancreatic ductal adenocarcinoma (PDAC). However, hyperbilirubinemia and the CA19-9 nonsecretor phenotype restrict the usage of serum CA19-9 alone. The goal of this study was to confirm the prognostic role of preope...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tao, Zhang, Min-Gui, Xu, Hua-Xiang, Wang, Wen-Quan, Liu, Liang, Yu, Xian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602572/
https://www.ncbi.nlm.nih.gov/pubmed/25984661
http://dx.doi.org/10.1097/MD.0000000000000751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602572/
https://www.ncbi.nlm.nih.gov/pubmed/25984661
http://dx.doi.org/10.1097/MD.0000000000000751

Ejemplares similares